The synthesized PLGA-encapsulated CRIF1 siRNA nanoparticles were administered by intratumoral injection, and CRIF1 gene-silencing was observed in tumor tissues (Figure 6A). This evidence concerns the gene GADD45GIP1 and neoplasm.